Neurodegeneration: From Genetics to Molecules
Chronic degenerative diseases are one of the major public health problems, particularly those affecting the nervous system. They are characterized by the degeneration of specific cell populations that include several pathologies which contribute significantly to morbidity and mortality in the elderl...
Saved in:
Superior document: | Frontiers Research Topics |
---|---|
: | |
Year of Publication: | 2016 |
Language: | English |
Series: | Frontiers Research Topics
|
Physical Description: | 1 electronic resource (264 p.) |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
id |
993543760404498 |
---|---|
ctrlnum |
(CKB)4100000002484642 (oapen)https://directory.doabooks.org/handle/20.500.12854/54496 (EXLCZ)994100000002484642 |
collection |
bib_alma |
record_format |
marc |
spelling |
Rosalinda Guevara-Guzman auth Neurodegeneration: From Genetics to Molecules Neurodegeneration Frontiers Media SA 2016 1 electronic resource (264 p.) text txt rdacontent computer c rdamedia online resource cr rdacarrier Frontiers Research Topics Chronic degenerative diseases are one of the major public health problems, particularly those affecting the nervous system. They are characterized by the degeneration of specific cell populations that include several pathologies which contribute significantly to morbidity and mortality in the elderly population. Therefore, in recent years, the study of neuroscience has gained significant importance. Most of these neurodegenerative disorders are the result of a complex interaction between genetic and environmental factors that generate progression and can even determine its severity. The presence of mutations in genes as LRRK2, SNCA, PARK7, PARK2 or PINK1 is associated with Parkinson's disease. Mutations in genes such as APP, PS1 and PS2 are associated with familial Alzheimer's disease; while HTT gene mutations are the cause of Huntington's disease. In most cases, this condition is inherited in an autosomal dominant pattern, which means one copy of the altered gene in each cell is sufficient to cause the disorder. It is known that these mutations can also alter the proteins function; however, it has not yet been possible to fully understand how some genetic changes cause the disease or influence the risk of developing these disorders. Most symptoms seen in these conditions occurs when specific nerve cells are damaged or die generating a loss in brain communication. Also many of these mutations generate aggregation of intracellular or extracellular proteins affecting cell function and eventually causing neuronal death. It is unclear whether the presence of these aggregates play an important role in nerve cell death during the development of neurodegenerative diseases, or if they are simply part of the response of cells to the disease. Other mutations affect the mitochondrial function generating alterations in energy production and promoting the formation of unstable molecules such as free radicals. Under normal conditions, the harmful effects caused by free radicals, are offset within the cell. However, in pathological conditions, the presence of mutations can alter this process by allowing the accumulation of radicals and damaging or killing cells. On the other hand, we also know that these diseases may not have a direct genetic component, thus, the study of sporadic type neurodegenerative diseases is much more complex. Histopathological lesions as well as the cellular and molecular alterations are generally indistinguishable from familial cases. For this reason, it is important to understand the genetic and molecular mechanisms associated with this type of pathologies. In this sense, this issue aims to understand the molecular processes that occur in the brain, and how these are influenced by the environment, genetics and behavior. English Sirtuins pleiotrophin Parkinson's disease Oxidative Stress epigenetic Epilepsy neurodegeneration Inflammation 5-lipoxygenase Alzheimer's disease 2-88945-020-1 Karla Guadalupe Carvajal auth Marco Antonio Meraz-Rios auth Victoria Campos-Pena auth |
language |
English |
format |
eBook |
author |
Rosalinda Guevara-Guzman |
spellingShingle |
Rosalinda Guevara-Guzman Neurodegeneration: From Genetics to Molecules Frontiers Research Topics |
author_facet |
Rosalinda Guevara-Guzman Karla Guadalupe Carvajal Marco Antonio Meraz-Rios Victoria Campos-Pena |
author_variant |
r g g rgg |
author2 |
Karla Guadalupe Carvajal Marco Antonio Meraz-Rios Victoria Campos-Pena |
author2_variant |
k g c kgc m a m r mamr v c p vcp |
author_sort |
Rosalinda Guevara-Guzman |
title |
Neurodegeneration: From Genetics to Molecules |
title_full |
Neurodegeneration: From Genetics to Molecules |
title_fullStr |
Neurodegeneration: From Genetics to Molecules |
title_full_unstemmed |
Neurodegeneration: From Genetics to Molecules |
title_auth |
Neurodegeneration: From Genetics to Molecules |
title_alt |
Neurodegeneration |
title_new |
Neurodegeneration: From Genetics to Molecules |
title_sort |
neurodegeneration: from genetics to molecules |
series |
Frontiers Research Topics |
series2 |
Frontiers Research Topics |
publisher |
Frontiers Media SA |
publishDate |
2016 |
physical |
1 electronic resource (264 p.) |
isbn |
2-88945-020-1 |
illustrated |
Not Illustrated |
work_keys_str_mv |
AT rosalindaguevaraguzman neurodegenerationfromgeneticstomolecules AT karlaguadalupecarvajal neurodegenerationfromgeneticstomolecules AT marcoantoniomerazrios neurodegenerationfromgeneticstomolecules AT victoriacampospena neurodegenerationfromgeneticstomolecules AT rosalindaguevaraguzman neurodegeneration AT karlaguadalupecarvajal neurodegeneration AT marcoantoniomerazrios neurodegeneration AT victoriacampospena neurodegeneration |
status_str |
n |
ids_txt_mv |
(CKB)4100000002484642 (oapen)https://directory.doabooks.org/handle/20.500.12854/54496 (EXLCZ)994100000002484642 |
carrierType_str_mv |
cr |
hierarchy_parent_title |
Frontiers Research Topics |
is_hierarchy_title |
Neurodegeneration: From Genetics to Molecules |
container_title |
Frontiers Research Topics |
author2_original_writing_str_mv |
noLinkedField noLinkedField noLinkedField |
_version_ |
1787548485932810240 |
fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>04047nam-a2200433z--4500</leader><controlfield tag="001">993543760404498</controlfield><controlfield tag="005">20231214133346.0</controlfield><controlfield tag="006">m o d </controlfield><controlfield tag="007">cr|mn|---annan</controlfield><controlfield tag="008">202102s2016 xx |||||o ||| 0|eng d</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(CKB)4100000002484642</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(oapen)https://directory.doabooks.org/handle/20.500.12854/54496</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(EXLCZ)994100000002484642</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Rosalinda Guevara-Guzman</subfield><subfield code="4">auth</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Neurodegeneration: From Genetics to Molecules</subfield></datafield><datafield tag="246" ind1=" " ind2=" "><subfield code="a">Neurodegeneration</subfield></datafield><datafield tag="260" ind1=" " ind2=" "><subfield code="b">Frontiers Media SA</subfield><subfield code="c">2016</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 electronic resource (264 p.)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">Frontiers Research Topics</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Chronic degenerative diseases are one of the major public health problems, particularly those affecting the nervous system. They are characterized by the degeneration of specific cell populations that include several pathologies which contribute significantly to morbidity and mortality in the elderly population. Therefore, in recent years, the study of neuroscience has gained significant importance. Most of these neurodegenerative disorders are the result of a complex interaction between genetic and environmental factors that generate progression and can even determine its severity. The presence of mutations in genes as LRRK2, SNCA, PARK7, PARK2 or PINK1 is associated with Parkinson's disease. Mutations in genes such as APP, PS1 and PS2 are associated with familial Alzheimer's disease; while HTT gene mutations are the cause of Huntington's disease. In most cases, this condition is inherited in an autosomal dominant pattern, which means one copy of the altered gene in each cell is sufficient to cause the disorder. It is known that these mutations can also alter the proteins function; however, it has not yet been possible to fully understand how some genetic changes cause the disease or influence the risk of developing these disorders. Most symptoms seen in these conditions occurs when specific nerve cells are damaged or die generating a loss in brain communication. Also many of these mutations generate aggregation of intracellular or extracellular proteins affecting cell function and eventually causing neuronal death. It is unclear whether the presence of these aggregates play an important role in nerve cell death during the development of neurodegenerative diseases, or if they are simply part of the response of cells to the disease. Other mutations affect the mitochondrial function generating alterations in energy production and promoting the formation of unstable molecules such as free radicals. Under normal conditions, the harmful effects caused by free radicals, are offset within the cell. However, in pathological conditions, the presence of mutations can alter this process by allowing the accumulation of radicals and damaging or killing cells. On the other hand, we also know that these diseases may not have a direct genetic component, thus, the study of sporadic type neurodegenerative diseases is much more complex. Histopathological lesions as well as the cellular and molecular alterations are generally indistinguishable from familial cases. For this reason, it is important to understand the genetic and molecular mechanisms associated with this type of pathologies. In this sense, this issue aims to understand the molecular processes that occur in the brain, and how these are influenced by the environment, genetics and behavior.</subfield></datafield><datafield tag="546" ind1=" " ind2=" "><subfield code="a">English</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Sirtuins</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">pleiotrophin</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Parkinson's disease</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Oxidative Stress</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">epigenetic</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Epilepsy</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">neurodegeneration</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Inflammation</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">5-lipoxygenase</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Alzheimer's disease</subfield></datafield><datafield tag="776" ind1=" " ind2=" "><subfield code="z">2-88945-020-1</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Karla Guadalupe Carvajal</subfield><subfield code="4">auth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Marco Antonio Meraz-Rios</subfield><subfield code="4">auth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Victoria Campos-Pena</subfield><subfield code="4">auth</subfield></datafield><datafield tag="906" ind1=" " ind2=" "><subfield code="a">BOOK</subfield></datafield><datafield tag="ADM" ind1=" " ind2=" "><subfield code="b">2023-12-15 05:51:24 Europe/Vienna</subfield><subfield code="f">system</subfield><subfield code="c">marc21</subfield><subfield code="a">2018-03-10 17:16:05 Europe/Vienna</subfield><subfield code="g">false</subfield></datafield><datafield tag="AVE" ind1=" " ind2=" "><subfield code="i">DOAB Directory of Open Access Books</subfield><subfield code="P">DOAB Directory of Open Access Books</subfield><subfield code="x">https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&portfolio_pid=5337420710004498&Force_direct=true</subfield><subfield code="Z">5337420710004498</subfield><subfield code="b">Available</subfield><subfield code="8">5337420710004498</subfield></datafield></record></collection> |